FDA.reportPublic FDA data

0.1 ML ranibizumab 100 MG/ML Injection

RxCUI
2584857
RxNorm name
0.1 ML ranibizumab 100 MG/ML Injection
Display name
0.1 ML ranibizumab 100 MG/ML Injection
Full name
0.1 ML ranibizumab 100 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761197Susvimoranibizumab351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SusvimoRANIBIZUMABGenentech, Inc.9c6d9e2a-9a77-4d11-b692-de87cfde34442025-11-21Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2584857

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9c6d9e2a-9a77-4d11-b692-de87cfde3444ranibizumab 10 MG in 0.1 ML Injection [PSN] · 0.1 ML ranibizumab 100 MG/ML Injection [SCD] · ranibizumab 10 MG per 0.1 ML Injection [SY]314These highlights do not include all the information needed to use SUSVIMO safely and effectively. See full prescribing information for SUSVIMO. SUSVIMO ® (ranibizumab injection) for intravitreal use via SUSVIMO ocular implant Initial U.S. Approval: 200620251121